−1.48SEK
−60.39 MSEK
40.68 M
About SCANDION ONCOLOGY A/S
Sector
CEO
François R. Martelet
Headquarters
Copenhagen
Website
Employees (FY)
4
Founded
2017
ISIN
DK0061031895
FIGI
BBG00M4WQWJ7
Scandion Oncology A/S is a clinical-stage biotechnology company, which engages in the development of drugs for the treatment of cancers. Its lead product candidate is SCO-101, an oral compound that enhances the effects of standard anti-cancer treatment when given in combination and to reverse several types of drug resistance of cancer cells. The company was founded by Nils Aage Brünner, Jan Stenvang, and Kim Arvid Nielsen in 2017 and is headquartered in Copenhagen, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SCOL is 2.48 SEK — it has increased by 2.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange SCANDION ONCOLOGY A/S stocks are traded under the ticker SCOL.
SCOL stock is 9.79% volatile and has beta coefficient of −1.32. Check out the list of the most volatile stocks — is SCANDION ONCOLOGY A/S there?
One year price forecast for SCANDION ONCOLOGY A/S has a max estimate of 3.22 SEK and a min estimate of 3.22 SEK.
Yes, you can track SCANDION ONCOLOGY A/S financials in yearly and quarterly reports right on TradingView.
SCOL stock has fallen by 6.06% compared to the previous week, the month change is a 24.00% rise, over the last year SCANDION ONCOLOGY A/S has showed a 40.91% increase.
SCOL net income for the last quarter is −16.90 M SEK, while the quarter before that showed −16.02 M SEK of net income which accounts for −5.51% change. Track more SCANDION ONCOLOGY A/S financial stats to get the full picture.
Today SCANDION ONCOLOGY A/S has the market capitalization of 98.51 M, it has increased by 8.55% over the last week.
No, SCOL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SCOL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCANDION ONCOLOGY A/S stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 4.00 employees. See our rating of the largest employees — is SCANDION ONCOLOGY A/S on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SCANDION ONCOLOGY A/S technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SCANDION ONCOLOGY A/S stock shows the sell signal. See more of SCANDION ONCOLOGY A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SCANDION ONCOLOGY A/S future price: according to them, SCOL price has a max estimate of 3.22 SEK and a min estimate of 3.22 SEK. Read a more detailed SCANDION ONCOLOGY A/S forecast: see what analysts think of SCANDION ONCOLOGY A/S and suggest that you do with its stocks.